1. A Multicenter, Open-Label, Randomized Phase II Controlled Study of rh-Endostatin (Endostar) in Combination with Chemotherapy in Previously Untreated Extensive-Stage Small-Cell Lung Cancer. Issue 1 (January 2015) Authors: Lu, Shun; Li, Lu; Luo, Yi; Zhang, Li; Wu, Gang; Chen, Zhiwei; Huang, Cheng; Guo, Shuliang; Zhang, Yiping; Song, Xiangqun; Yu, Yongfeng; Zhou, Caicun; Li, Wei; Liao, Meilin; Li, Baolan; Xu, Liyan; Chen, Ping; Hu, Chunhong; Hu, Chengping Journal: Journal of thoracic oncology Issue: Volume 10:Issue 1(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A Multicenter, Open-Label, Randomized Phase II Controlled Study of rh-Endostatin (Endostar) in Combination with Chemotherapy in Previously Untreated Extensive-Stage Small-Cell Lung Cancer. Issue 1 (January 2015) Authors: Lu, Shun; Li, Lu; Luo, Yi; Zhang, Li; Wu, Gang; Chen, Zhiwei; Huang, Cheng; Guo, Shuliang; Zhang, Yiping; Song, Xiangqun; Yu, Yongfeng; Zhou, Caicun; Li, Wei; Liao, Meilin; Li, Baolan; Xu, Liyan; Chen, Ping; Hu, Chunhong; Hu, Chengping Journal: Journal of thoracic oncology Issue: Volume 10:Issue 1(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Assessment of interfering factors and clinical risk associated with discontinuation of pemetrexed maintenance therapy in advanced non-squamous non-small cell lung cancer. (September 2017) Authors: Shen, Lan; Niu, Xiaomin; Jian, Hong; Xu, Yunhua; Yu, Yongfeng; Lu, Shun Journal: Lung cancer Issue: Volume 111(2017) Page Start: 43 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Circulating tumour DNA biomarkers in savolitinib-treated patients with non-small cell lung cancer harbouring MET exon 14 skipping alterations: a post hoc analysis of a pivotal phase 2 study. (October 2022) Authors: Yu, Yongfeng; Ren, Yongxin; Fang, Jian; Cao, Lejie; Liang, Zongan; Guo, Qisen; Han, Sen; Ji, Zimei; Wang, Ye; Sun, Yulan; Chen, Yuan; Li, Xingya; Xu, Hua; Zhou, Jianying; Jiang, Liyan; Cheng, Ying; Han, Zhigang; Shi, Jianhua; Chen, Gongyan; Ma, Rui Journal: Therapeutic advances in medical oncology Issue: Volume 14(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Comprehensive analysis of MET mutations in NSCLC patients in a real-world setting. (July 2022) Authors: Ai, Xinghao; Yu, Yongfeng; Zhao, Jun; Sheng, Wang; Bai, Jing; Fan, Zaiwen; Liu, Xuemei; Ji, Wenxiang; Chen, Rongrong; Lu, Shun Journal: Therapeutic advances in medical oncology Issue: Volume 14(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Concomitant resistance mechanisms to multiple tyrosine kinase inhibitors in ALK-positive non-small cell lung cancer. (January 2019) Authors: Yu, Yongfeng; Ou, Qiuxiang; Wu, Xue; Bao, Hairong; Ding, Yan; Shao, Yang W.; Lu, Shun Journal: Lung cancer Issue: Volume 127(2019) Page Start: 19 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Correlation of clinicopathologic features and lung squamous cell carcinoma subtypes according to the 2015 WHO classification. Issue 12 (December 2017) Authors: Chen, Rongrong; Ding, Zhengping; Zhu, Lei; Lu, Shun; Yu, Yongfeng Journal: European journal of surgical oncology Issue: Volume 43:Issue 12(2017:Dec.) Page Start: 2308 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Corrigendum to "The Hippo/YAP1 pathway interacts with FGFR1 signaling to maintain stemness in lung cancer" [Canc. Lett. 423 (2018) 36–46]. (1st September 2018) Authors: Lu, Tingting; Li, Ziming; Yang, Ying; Ji, Wenxiang; Yu, Yongfeng; Niu, Xiaomin; Zeng, Qingyu; Xia, Weiliang; Lu, Shun Journal: Cancer letters Issue: Volume 431(2018) Page Start: 244 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. EptA of Riemerella anatipestifer mediates phenotypes involved in colistin resistance and virulence. Issue 5 (18th April 2023) Authors: Chen, Qiwei; Quan, Heng; Yu, Yongfeng; Liu, Donghui; Li, Caiyu; Chu, Yuefeng; Gong, Xiaowei Journal: FASEB journal Issue: Volume 37:Issue 5(2023) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. First‐line crizotinib versus platinum‐pemetrexed chemotherapy in patients with advanced ROS1‐rearranged non‐small‐cell lung cancer. (13th March 2020) Authors: Shen, Lan; Qiang, Tan; Li, Ziming; Ding, Ding; Yu, Yongfeng; Lu, Shun Journal: Cancer medicine Issue: Volume 9:Number 10(2020) Page Start: 3310 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗